Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
NCT ID: NCT01005251
Description: As a consequence of the definition of the analysis set for efficacy analysis and safety analysis respectively, one patient was included in the 120 mg group for efficacy analyses and in the 60 mg group for safety analyses.
Frequency Threshold: 5
Time Frame: None
Study: NCT01005251
Study Brief: Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AZD3355 60 mg PPI+AZD3355 60 mg twice daily (bid) None None 0 None 13 None View
AZD3355 120 mg PPI+AZD3355 120 mg twice daily (bid) None None 0 None 12 None View
AZD3355 180 mg PPI+AZD3355 180 mg twice daily (bid) None None 0 None 16 None View
AZD3355 240 mg PPI+AZD3355 240 mg twice daily (bid) None None 1 None 20 None View
Placebo PPI+Placebo None None 1 None 9 None View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Non-Cardiac Chest Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 13.0 View
Metastatic Gastric Cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 13.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 13.0 View
Paraesthesia None Nervous system disorders MedDRA 13.0 View